ATE289812T1 - Azolylcarbynol-derivative von aryl (oder heteroaryl) zur behandlung von atemwegserkrankungen - Google Patents

Azolylcarbynol-derivative von aryl (oder heteroaryl) zur behandlung von atemwegserkrankungen

Info

Publication number
ATE289812T1
ATE289812T1 AT02714232T AT02714232T ATE289812T1 AT E289812 T1 ATE289812 T1 AT E289812T1 AT 02714232 T AT02714232 T AT 02714232T AT 02714232 T AT02714232 T AT 02714232T AT E289812 T1 ATE289812 T1 AT E289812T1
Authority
AT
Austria
Prior art keywords
heteroaryl
aryl
treatment
derivatives
azolylcarbynol
Prior art date
Application number
AT02714232T
Other languages
English (en)
Inventor
Ramon Merce-Vidal
Blas Andaluz-Matero
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Application granted granted Critical
Publication of ATE289812T1 publication Critical patent/ATE289812T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02714232T 2001-04-06 2002-03-21 Azolylcarbynol-derivative von aryl (oder heteroaryl) zur behandlung von atemwegserkrankungen ATE289812T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200100817A ES2174756B2 (es) 2001-04-06 2001-04-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
PCT/ES2002/000136 WO2002080908A1 (es) 2001-04-06 2002-03-21 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias

Publications (1)

Publication Number Publication Date
ATE289812T1 true ATE289812T1 (de) 2005-03-15

Family

ID=8497368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02714232T ATE289812T1 (de) 2001-04-06 2002-03-21 Azolylcarbynol-derivative von aryl (oder heteroaryl) zur behandlung von atemwegserkrankungen

Country Status (22)

Country Link
US (1) US20040142994A1 (de)
EP (1) EP1384476B1 (de)
JP (1) JP2004531511A (de)
KR (1) KR20040025913A (de)
CN (1) CN1230165C (de)
AT (1) ATE289812T1 (de)
AU (1) AU2002246151B2 (de)
BR (1) BR0208807A (de)
CA (1) CA2443015A1 (de)
DE (1) DE60203106T2 (de)
DK (1) DK1384476T3 (de)
ES (2) ES2174756B2 (de)
HU (1) HUP0400925A3 (de)
IL (1) IL158268A0 (de)
MX (1) MXPA03009125A (de)
NO (1) NO20034471L (de)
NZ (1) NZ529303A (de)
PL (1) PL365251A1 (de)
PT (1) PT1384476E (de)
RU (1) RU2294198C2 (de)
WO (1) WO2002080908A1 (de)
ZA (1) ZA200308630B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10335566A1 (de) * 2003-07-31 2005-02-24 Grünenthal GmbH Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
EP1584335A3 (de) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Zusammensetzung aus Aktiva mit einer Carbinolverbindung und einem Opioid
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1632227A1 (de) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Aryl- (oder Heteroaryl-) Azolcarbinole (insbesondere Cizolirtin Citrate) für die Behandlung von Opioid Abhängigkeit
EP1820502A1 (de) * 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Wirkstoffzusammensetzungen enthaltend Azolycarbinolderivate
US20100291151A1 (en) * 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.

Also Published As

Publication number Publication date
CN1230165C (zh) 2005-12-07
MXPA03009125A (es) 2005-04-11
HUP0400925A2 (hu) 2004-07-28
RU2003132456A (ru) 2005-04-10
JP2004531511A (ja) 2004-10-14
AU2002246151C1 (en) 2002-10-21
EP1384476B1 (de) 2005-03-02
PL365251A1 (en) 2004-12-27
US20040142994A1 (en) 2004-07-22
HUP0400925A3 (en) 2004-10-28
PT1384476E (pt) 2005-05-31
ES2174756B2 (es) 2003-11-16
RU2294198C2 (ru) 2007-02-27
ES2236497T3 (es) 2005-07-16
ZA200308630B (en) 2004-11-05
NO20034471L (no) 2003-12-03
KR20040025913A (ko) 2004-03-26
DE60203106D1 (de) 2005-04-07
CN1535147A (zh) 2004-10-06
IL158268A0 (en) 2004-05-12
AU2002246151B2 (en) 2007-05-31
DK1384476T3 (da) 2005-05-30
WO2002080908A1 (es) 2002-10-17
NZ529303A (en) 2005-06-24
NO20034471D0 (no) 2003-10-06
EP1384476A1 (de) 2004-01-28
DE60203106T2 (de) 2006-04-13
ES2174756A1 (es) 2002-11-01
CA2443015A1 (en) 2002-10-17
BR0208807A (pt) 2004-07-13

Similar Documents

Publication Publication Date Title
GEP20104973B (en) Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
NO20064599L (no) Substituerte morfolin- og tiomorfolinderivater
EA200500304A1 (ru) Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний
NO20084997L (no) Pyrazolo[3,4-D]pyrimidinderivater nyttige for a behandle andedrettssykdommer
NO20062983L (no) Sulfonamid-derivater for behandling av sykdommer
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
NO20054852L (no) GFAT inhibitorer
NO20064577L (no) Tetrahydronaftyndin-derivater nyttige som histamin H3 reseptorligander
CY1110676T1 (el) ΠΥΡΑΖΟΛΟ[3,4-b]ΠΥΡΙΔΙΝΙΚΕΣ ΕΝΩΣΕΙΣ, ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ ΦΩΣΦΟΔΙΕΣΤΕΡΑΣΗΣ
LTC1755590I2 (lt) Glikopirolato ir beta2 adrenoceptoriaus agonisto derinys
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
NO20074441L (no) 1-benzylindol-2-karboksamidderivater
MX336345B (es) Derivados de purina para usarse en el tratamiento de enfermedades alergicas, inflamatorias e infecciosas.
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
NO20075169L (no) Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme.
CY1105113T1 (el) Παραγωγα της αρυλικης (ή ετepοαρυλικης) αζολυλκαρβυνολης για την αντιμετωπιση της ακρατειας ουρων
NO20065327L (no) Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
TW200619212A (en) Morpholine derivatives
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
ATE492534T1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
NO20054721L (no) Substituerte anilinderivater
ATE289812T1 (de) Azolylcarbynol-derivative von aryl (oder heteroaryl) zur behandlung von atemwegserkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1384476

Country of ref document: EP

REN Ceased due to non-payment of the annual fee